Direkt zum Inhalt
Merck
  • Systemic and local toxicity in the rat of methyl tert-butyl ether: a gallstone dissolution agent.

Systemic and local toxicity in the rat of methyl tert-butyl ether: a gallstone dissolution agent.

The Journal of surgical research (1992-12-01)
R Akimoto, E Rieger, A R Moossa, A F Hofmann, H E Wahlstrom
ZUSAMMENFASSUNG

Methyl tert-butyl ether (MTBE) is an organic solvent that has been used to dissolve gallstones via a percutaneous transhepatic catheter into the gallbladder. To test whether MTBE might cause serious tissue injury if accidentally infused outside the gallbladder, the effect of MTBE (0.2 ml/kg) injected into the hepatic parenchyma, or administered intravenously or intraperitoneally, was examined in the rat. The toxicity of isopropyl acetate (IPA), an organic solvent with a similar chemical structure, was examined similarly. Intracaval injection of MTBE caused the highest mortality (100%). Mortality was less (59%) after intrahepatic injection and still less (17%) after peripheral vein injection. Most animals died instantaneously from cardiorespiratory arrest. Almost all animals that were injected with MTBE intrahepatically or intravenously showed localized areas of congestion, hemorrhage, and interstitial edema in the lungs. These changes were more severe in rats which survived for 24 hr than in those which died sooner. In those rats receiving intrahepatic injections, most rats which survived for 24 hr had liver necrosis at the site of injection. Intraperitoneal injection of MTBE produced 100% survival with only 1/5 rats showing a mild pulmonary injury at autopsy. IPA had toxic effects similar to those evoked by MTBE. To test whether tumor necrosis factor was involved in organ injury, serum levels were measured; they remained unchanged. These experiments indicate that two organic solvents, MTBE and IPA, are cytotoxic to local tissues and cause severe, and often fatal, lung damage when infused into a central vein. Less toxicity occurred if solvents were given into a peripheral or portal vein or intraperitoneally.(ABSTRACT TRUNCATED AT 250 WORDS)

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Essigsäureisopropylester, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Essigsäureisopropylester, ≥99.6%
Sigma-Aldrich
Essigsäureisopropylester, 98%
Supelco
Essigsäureisopropylester, analytical standard
Sigma-Aldrich
Essigsäureisopropylester, ≥99%, FCC